OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 48
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity—ORCHESTRA Project
Luca Cegolon, Marcella Mauro, Donatella Sansone, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1769-1769
Open Access | Times Cited: 23
Luca Cegolon, Marcella Mauro, Donatella Sansone, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1769-1769
Open Access | Times Cited: 23
Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters
Rana Abdelnabi, Ria Lassaunière, Piet Maes, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 122-122
Open Access | Times Cited: 7
Rana Abdelnabi, Ria Lassaunière, Piet Maes, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 122-122
Open Access | Times Cited: 7
Pediatric COVID-19 severity by SARS-CoV-2 lineage and vaccine status in Canada: an IMPACT study
Daniel S. Farrar, Julie A. Bettinger, Aaron Campigotto, et al.
Pediatric Research (2025)
Closed Access
Daniel S. Farrar, Julie A. Bettinger, Aaron Campigotto, et al.
Pediatric Research (2025)
Closed Access
Characteristics and Outcomes of Children Hospitalized With COVID-19 During Early Pandemic and Delta Variant
L Denise Willis, Beverly J. Spray, Erin Henderson, et al.
Respiratory Care (2025)
Closed Access
L Denise Willis, Beverly J. Spray, Erin Henderson, et al.
Respiratory Care (2025)
Closed Access
Incidence, severity, risk factors and outcomes of SARS-CoV-2 reinfections during the Omicron period: a systematic review and meta-analysis
Durga Kulkarni, Bohee Lee, Nabihah Farhana Ismail, et al.
Journal of Global Health (2025) Vol. 15
Open Access
Durga Kulkarni, Bohee Lee, Nabihah Farhana Ismail, et al.
Journal of Global Health (2025) Vol. 15
Open Access
Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update
Fabian Termorshuizen, Dave A. Dongelmans, Sylvia Brinkman, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Fabian Termorshuizen, Dave A. Dongelmans, Sylvia Brinkman, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
From Archipelago to Pandemic Battleground: Unveiling Indonesia’s COVID-19 Crisis
Biyan Nathanael Harapan, Triswan Harapan, Lenny Theodora, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 4, pp. 591-603
Open Access | Times Cited: 11
Biyan Nathanael Harapan, Triswan Harapan, Lenny Theodora, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 4, pp. 591-603
Open Access | Times Cited: 11
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination
Alexander Hönning, Sara Tomczyk, Júlia Hermes, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Alexander Hönning, Sara Tomczyk, Júlia Hermes, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
The Course of COVID-19 and Long COVID: Identifying Risk Factors among Patients Suffering from the Disease before and during the Omicron-Dominant Period
Mateusz Babicki, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.
Pathogens (2024) Vol. 13, Iss. 3, pp. 267-267
Open Access | Times Cited: 3
Mateusz Babicki, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.
Pathogens (2024) Vol. 13, Iss. 3, pp. 267-267
Open Access | Times Cited: 3
Iterative In Silico Screening for Optimizing Stable Conformation of Anti-SARS-CoV-2 Nanobodies
Wenyuan Shang, Xiujun Hu, Xiaoman Lin, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 424-424
Open Access | Times Cited: 2
Wenyuan Shang, Xiujun Hu, Xiaoman Lin, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 424-424
Open Access | Times Cited: 2
Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection
Alexandra Domnica Hoeggerl, Verena Nunhofer, Lisa Weidner, et al.
Infectious Diseases (2024), pp. 1-11
Open Access | Times Cited: 2
Alexandra Domnica Hoeggerl, Verena Nunhofer, Lisa Weidner, et al.
Infectious Diseases (2024), pp. 1-11
Open Access | Times Cited: 2
Tracking SARS-CoV-2 RNA in the Air: Lessons from a COVID-19 Outbreak in an Infirmary Unit
Shuk‐Ching Wong, Jonathan Hon-Kwan Chen, Pui Hing Chau, et al.
American Journal of Infection Control (2024)
Closed Access | Times Cited: 2
Shuk‐Ching Wong, Jonathan Hon-Kwan Chen, Pui Hing Chau, et al.
American Journal of Infection Control (2024)
Closed Access | Times Cited: 2
Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early‐stage symptomatic COVID‐19: A real‐life experience
José María Caso, Mario Fernández‐Ruiz, Francisco López‐Medrano, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 7
José María Caso, Mario Fernández‐Ruiz, Francisco López‐Medrano, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 7
Application of the screening method for estimating COVID-19 vaccine effectiveness using routine surveillance data: Germany’s experience during the COVID-19 pandemic, July 2021 to March 2023
Nita Perumal, Viktoria Schönfeld, Ole Wichmann
Eurosurveillance (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 1
Nita Perumal, Viktoria Schönfeld, Ole Wichmann
Eurosurveillance (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 1
Novel travel time aware metapopulation models: A combination with multi-layer waning immunity to assess late-phase epidemic and endemic scenarios
Henrik Zunker, René Schmieding, David Kerkmann, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Henrik Zunker, René Schmieding, David Kerkmann, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Ingresos COVID-19: intentando comprender el impacto real de la infección en pacientes hospitalizados
Claudia Solito, María Hernández, Noelia Arguedas Casamayor, et al.
Anales de Pediatría (2024) Vol. 100, Iss. 5, pp. 342-351
Open Access | Times Cited: 1
Claudia Solito, María Hernández, Noelia Arguedas Casamayor, et al.
Anales de Pediatría (2024) Vol. 100, Iss. 5, pp. 342-351
Open Access | Times Cited: 1
COVID-19 admissions: Trying to define the real impact of infection in hospitalized patients
Claudia Solito, María Hernández, Noelia Arguedas Casamayor, et al.
Anales de Pediatría (English Edition) (2024) Vol. 100, Iss. 5, pp. 342-351
Open Access | Times Cited: 1
Claudia Solito, María Hernández, Noelia Arguedas Casamayor, et al.
Anales de Pediatría (English Edition) (2024) Vol. 100, Iss. 5, pp. 342-351
Open Access | Times Cited: 1
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study
Hee Jo Han, Seung Woo Kim, Hyunjin Kim, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 18
Open Access | Times Cited: 1
Hee Jo Han, Seung Woo Kim, Hyunjin Kim, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 18
Open Access | Times Cited: 1
The Asymptomatic Proportion of SARS‐CoV‐2 Omicron Variant Infections in Households: A Systematic Review
Nancy D. J. Shi, Adrian J. Marcato, Violeta Spirkoska, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 7
Open Access | Times Cited: 1
Nancy D. J. Shi, Adrian J. Marcato, Violeta Spirkoska, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 7
Open Access | Times Cited: 1
Real-world effectiveness of nirmatrelvir-ritonavir and molnupiravir in non-hospitalised adults with Covid-19: a population-based, retrospective cohort study cohort study
Anselm Jorda, Dominik Ensle, Hatice Eser, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 1
Anselm Jorda, Dominik Ensle, Hatice Eser, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 1
Sex Differences in Long-Term Cardiovascular Outcomes and Mortality After COVID-19 Hospitalization During Alpha, Delta and Omicron Waves
Kristen Kopp, Lukas J. Motloch, Michael Lichtenauer, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6636-6636
Open Access | Times Cited: 1
Kristen Kopp, Lukas J. Motloch, Michael Lichtenauer, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6636-6636
Open Access | Times Cited: 1
Novel travel time aware metapopulation models and multi-layer waning immunity for late-phase epidemic and endemic scenarios
Henrik Zunker, René Schmieding, David Kerkmann, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 12, pp. e1012630-e1012630
Open Access | Times Cited: 1
Henrik Zunker, René Schmieding, David Kerkmann, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 12, pp. e1012630-e1012630
Open Access | Times Cited: 1
Real-world effectiveness of azvudine for patients infected with the SARS-CoV-2 omicron subvariant BA.5 in an intensive care unit
Xiuping QI, Yun Yang, Baoqiang Gong, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 9, pp. 4925-4937
Open Access | Times Cited: 3
Xiuping QI, Yun Yang, Baoqiang Gong, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 9, pp. 4925-4937
Open Access | Times Cited: 3
Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID
Junzheng Wu, Huichuan Yang, Ding Yu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 2
Junzheng Wu, Huichuan Yang, Ding Yu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 2
COVID-19 and Surgery: Getting Back to Business
Paul S. Myles
Anesthesiology (2024) Vol. 140, Iss. 2, pp. 183-185
Closed Access
Paul S. Myles
Anesthesiology (2024) Vol. 140, Iss. 2, pp. 183-185
Closed Access